Outcomes of partially covered self-expandable metal stents with different uncovered lengths in endoscopic ultrasound-guided hepaticogastrostomy: a Japanese retrospective study
Authors:
- Takeshi OkamotoTOTakeshi Okamoto
- Takashi SasakiTSTakashi Sasaki
- Tsuyoshi TakedaTTTsuyoshi Takeda
- Tatsuki HiraiTHTatsuki Hirai
- Takahiro IshitsukaTITakahiro Ishitsuka
- Manabu YamadaMYManabu Yamada
- Hiroki NakagawaHNHiroki Nakagawa
- Takafumi MieTMTakafumi Mie
- Takaaki FurukawaTFTakaaki Furukawa
- Akiyoshi KasugaAKAkiyoshi Kasuga
- Masato OzakaMOMasato Ozaka
- Naoki SasahiraNSNaoki Sasahira
Open Access
- 30 July 2024
- journal article
- research article
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (4) , 515-526
Abstract
Background/Aims: The optimal length of the uncovered portion of partially covered self-expandable metal stents (PCSEMSs) used in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) remains unclear. This study investigated the safety and efficacy of PCSEMSs with different uncovered lengths, with a focus on stent migration and time to recurrent biliary obstruction (RBO).Methods: Outcomes of patients undergoing EUS-HGS using PCSEMSs with 5-mm and 20-mm uncovered portions at our institution from January 2016 to December 2021 were compared.Results: Sixty-two patients underwent EUS-HGS using PCSEMS (5/20-mm uncovered portions: 32/30). Stent migration occurred only in the 5-mm group. There were no differences in RBO rates (28.1% vs. 40.0%) or median time to RBO (6.8 vs. 7.1 months) between the two groups. Median overall survival (OS) was longer in the 20-mm group (3.1 vs. 4.9 months, p=0.037) due to the higher number of patients that resumed chemotherapy after EUS-HGS (56.7% vs. 28.1%, p=0.029). Good performance status, absence of hepatic metastases, and chemotherapy after EUS-HGS were independent predictors of longer OS.Conclusions: No migration was observed in patients treated with PCSEMS with 20-mm uncovered portions. Patients treated with PCSEMS with 20-mm uncovered portions performed at least as well as those treated with 5-mm uncovered portions in all material respects.Keywords
This publication has 29 references indexed in Scilit:
- Endoscopic ultrasound-guided hepaticogastrostomy using a partially covered metal stent in patients with malignant biliary obstruction after failedEndoscopic retrograde cholangiopancreatographyJGH Open, 2020
- Long-term outcomes of a long, partially covered metal stent for EUS-guided hepaticogastrostomy in patients with malignant biliary obstruction (with video)Gastrointestinal Endoscopy, 2020
- Clinical practice guidelines for safe performance of endoscopic ultrasound/ultrasonography‐guided biliary drainage: 2018Journal of Hepato-Biliary-Pancreatic Sciences, 2019
- Clinical Impact of the Intra-scope Channel Stent Release Technique in Preventing Stent Migration During EUS-Guided HepaticogastrostomyJournal of Gastrointestinal Surgery, 2018
- Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage (with videos)Gastrointestinal Endoscopy, 2017
- Assessment of efficacy and safety of EUS-guided biliary drainage: a systematic reviewGastrointestinal Endoscopy, 2016
- Hepaticogastrostomy or choledochoduodenostomy for distal malignant biliary obstruction after failed ERCP: Is there any difference?Gastrointestinal Endoscopy, 2015
- Endoscopic ultrasound-guided hepaticogastrostomy for advanced cholangiocarcinoma after failed stenting by endoscopic retrograde cholangiopancreatographyAsian Journal of Surgery, 2013
- A lexicon for endoscopic adverse events: report of an ASGE workshopGastrointestinal Endoscopy, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009